Correlation Between Exicure and Puma Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exicure and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exicure and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exicure and Puma Biotechnology, you can compare the effects of market volatilities on Exicure and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exicure with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exicure and Puma Biotechnology.

Diversification Opportunities for Exicure and Puma Biotechnology

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Exicure and Puma is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Exicure and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Exicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exicure are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Exicure i.e., Exicure and Puma Biotechnology go up and down completely randomly.

Pair Corralation between Exicure and Puma Biotechnology

Given the investment horizon of 90 days Exicure is expected to generate 9.85 times more return on investment than Puma Biotechnology. However, Exicure is 9.85 times more volatile than Puma Biotechnology. It trades about 0.35 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.11 per unit of risk. If you would invest  394.00  in Exicure on September 18, 2024 and sell it today you would earn a total of  1,330  from holding Exicure or generate 337.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Exicure  vs.  Puma Biotechnology

 Performance 
       Timeline  
Exicure 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exicure are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Exicure reported solid returns over the last few months and may actually be approaching a breakup point.
Puma Biotechnology 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Exicure and Puma Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exicure and Puma Biotechnology

The main advantage of trading using opposite Exicure and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exicure position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.
The idea behind Exicure and Puma Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets